Pharmaceutical / Drug Definition :
Inhibits conversion of angiotensin I to angiotensin II, a potent vasoconstrictor; decreases cardiac output. Increases plasma renin levels and reduces aldosterone levels, causing systemic vasodilation.
FDA Label Requirements and Exceptions
Quinapril Hydrochloride
FDA Import Information
Quinapril Hydrochloride
FDA Detentions
Quinapril Hydrochloride (Quinapril Hydrochloride Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Quinapril Hydrochloride (Quinapril Hydrochloride Suppliers)
- Processors Quinapril Hydrochloride
- Repackers Quinapril Hydrochloride
- Relabelers Quinapril Hydrochloride
- Exporters Quinapril Hydrochloride
- Importers Quinapril Hydrochloride
For more information about Quinapril Hydrochloride, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
